Table 2

ESCC patient characteristics and USP9X expression
Characteristic Total (n = 102) No. of USP9X positive expression cases (%) P value
Age (years) 0.961
≤59 60 24 (40.0)
≥60 42 17 (40.5)
Gender 0.928
Male 85 34 (40.0)
Female 17 7 (41.2)
Location 0.763
Upper 6 2 (33.3)
Middle 75 29 (38.7)
Lower 21 10 (47.6)
Tumor length 0.717
≤5 cm 60 25 (41.7)
>5 cm 42 16 (38.1)
Histological grades 0.123
G1a 22 13 (59.1)
G2a 58 20 (34.5)
G3a 22 8 (36.4)
Depth of invasion 0.046
T1-T2 57 18 (31.6)
T3-T4 45 23 (51.1)
Lymph node metastasis 0.032
Positive 49 25 (51.0)
Negative 53 16 (30.2)
TNM stage 0.112
I-II 57 19 (33.3)
III-IV 45 22 (48.9)

aG3, well-differentiated carcinoma; G2, moderately-differentiated carcinoma; G1, poorly-differentiated carcinoma.

Peng et al.

Peng et al. Diagnostic Pathology 2013 8:177   doi:10.1186/1746-1596-8-177

Open Data